insurance coverage semaglutide for Weight Loss Insurance coverage just changed for

I cant believe that pharma would actually want to cure an obese person as that represents opportunity lost in recurring revenue

Labeling hair pulling as a bad habit ignores the complexities and profound emotional pain associated with the disorder

SPRINT MIND Investigators, 2019), and the lack of conclusive evidence of effect from these trials may be in part attributable to the variation in blood pressure target levels and the assessment of cognitive outcomes (SPRINT MIND Investigators, 2019)

Imagine Drucker submitting a grant proposal today titled "Investigating Gila Monster Venom Proteins for Potential Therapeutic Applications." How would reviewers respond to: Unclear commercial potential No obvious connection to existing treatment paradigms High risk of "failure" (most venom studies don't yield drugs) Difficult to measure short-term impact Traditional funding metrics, publication counts, citation indices, immediate clinical relevance, would likely work against such proposals